227 related articles for article (PubMed ID: 7602073)
1. Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis.
Caselmann WH
J Hepatol; 1995; 22(1 Suppl):34-7. PubMed ID: 7602073
[TBL] [Abstract][Full Text] [Related]
2. Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators.
Schlüter V; Meyer M; Hofschneider PH; Koshy R; Caselmann WH
Oncogene; 1994 Nov; 9(11):3335-44. PubMed ID: 7936659
[TBL] [Abstract][Full Text] [Related]
3. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
Kim DG
Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
[TBL] [Abstract][Full Text] [Related]
4. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation.
Lauer U; Weiss L; Lipp M; Hofschneider PH; Kekulé AS
Hepatology; 1994 Jan; 19(1):23-31. PubMed ID: 8276360
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
6. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D
Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796
[TBL] [Abstract][Full Text] [Related]
7. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance.
Chen WN; Oon CJ; Leong AL; Koh S; Teng SW
Biochem Biophys Res Commun; 2000 Oct; 276(3):885-92. PubMed ID: 11027564
[TBL] [Abstract][Full Text] [Related]
8. [Gene expression profile in response to hepatitis B virus X gene by using an adenoviral vector].
Joo HY; Han KH; Ryu WS
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):371-80. PubMed ID: 12506241
[TBL] [Abstract][Full Text] [Related]
9. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
10. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
Tu H; Gao HF; Ma GH; Liu Y
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
[TBL] [Abstract][Full Text] [Related]
11. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator.
Kekulé AS; Lauer U; Meyer M; Caselmann WH; Hofschneider PH; Koshy R
Nature; 1990 Feb; 343(6257):457-61. PubMed ID: 2153938
[TBL] [Abstract][Full Text] [Related]
12. HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.
Shamay M; Agami R; Shaul Y
Oncogene; 2001 Oct; 20(47):6811-9. PubMed ID: 11687960
[TBL] [Abstract][Full Text] [Related]
13. Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro.
Luber B; Arnold N; Stürzl M; Höhne M; Schirmacher P; Lauer U; Wienberg J; Hofschneider PH; Kekulé AS
Oncogene; 1996 Apr; 12(8):1597-608. PubMed ID: 8622879
[TBL] [Abstract][Full Text] [Related]
14. [Trans-activating function of integrated hepatitis B virus].
Nakatake H; Yamamoto S; Matsubara K
Nihon Rinsho; 1993 Feb; 51(2):357-63. PubMed ID: 8385237
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus and hepatocellular carcinoma: a possible role for the viral transactivators.
Levrero M; Balsano C; Avantaggiati ML; Natoli G; De Marzio E; Will H
Ital J Gastroenterol; 1991 Dec; 23(9):576-83. PubMed ID: 1662093
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.
Sirma H; Giannini C; Poussin K; Paterlini P; Kremsdorf D; Bréchot C
Oncogene; 1999 Aug; 18(34):4848-59. PubMed ID: 10490818
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
[TBL] [Abstract][Full Text] [Related]
19. [Gene expression of hepatitis viruses in the liver and hepatocarcinogenesis].
Koike K
Hum Cell; 1992 Jun; 5(2):150-9. PubMed ID: 1327091
[TBL] [Abstract][Full Text] [Related]
20. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]